|
|
 |
 |  |  | | | |  Clinical and Scientific Calendar
- CINP 2008 - 50th Anniversary
July 13-17, 2008
Internationales Congress Center Munchen
Munich, Germany
Presenter: Geoffrey C. Dunbar, M.D., Vice President, Clinical Development and Regulatory Affairs, Targacept
Poster: Effect of Nicotinic Antagonism on Irritability in Depressed Patients Who Were Partial or Non Responders to Citalopram First Line Therapy: A Mecamylamine Double Blind Placebo Controlled Study
Wednesday, July 16, 5- 7 p.m.
- 2008 BIO International Convention
June 17-20, 2008
San Diego Convention Center
San Diego, CA
Panelist: Jeffrey Brennan, Vice-President, Business and Commercial Development, Targacept
Presentation: New Biotech-Pharma Partnership Models That Retain Greater Value
Tuesday, June 17, 4:00 - 5:30 p.m.
Panelist: Don deBethizy, Ph.D., President & CEO, Targacept
Presentation: The Early Bird Gets the Worm: Extracting Value out of Your Early-Stage Pipeline
Wednesday, June 18, 10:15 - 11:45 a.m.
- Nicotinic Acetylcholine Receptors 2008
April 23 - 28, 2008
Wellcome Trust Conference Center
Wellcome Trust Genome Campus
Hinxton
Cambridgeshire
Presenters: Merourane Bencherif, MD, Ph.D., Vice President, Preclinical Research and Pat Lippiello, Ph.D., Senior Director, Project Planning and Scientific Communication, Targacept
Poster: Differential Effects of TC-5214 [S-(+)-mecamylamine] and TC-5213
[R-(-)-mecamylamine] at Low and High Sensitivity Human a4b2 Nicotinic Receptors and in Animal Models of Depression and Anxiety
Presenter: Kristen Jordan, Ph.D., Group Leader, Behavioral Neuroscience
Poster: TC-6499: An Orally Effective and Selective alpha4beta2 Neuronal Nicotinic Receptor Agonist with Anti-allodynic Activity
April 6 - 10, 2008 Morial Convention Center New Orleans, Louisiana
Presenter: David C. Kombo, Ph.D., Sr. Computational Scientist Poster: Predicting Ligand Binding Affinity to the Rat alpha4beta2 Neuronal Nicotinic Receptor: Lessons from Bayesian Categorization Modeling
- American College of Neuropsychopharmacology - 46th Annual Meeting
December 9-13, 2007
Boca Raton Resort and Conference Center
Boca Raton, FL, USA
Presenter: Geoffrey C. Dunbar, M.D., Vice President, Clinical Development and Regulatory Affairs, Targacept
Monday, December 10, 2007, 5:30-7:30 p.m.
Poster: Mecamylamine in the treatment for depressed patients who were poor responders to citalopram first line therapy; a double-blind placebo controlled study.
- Society for Neuroscience Annual Meeting
November 3-7, 2007
San Diego Convention Center
San Diego, CA, USA
Saturday, November 3, 2007 at 2 p.m., #39.2, Board F33
Presenter: Nikolai Fedorov, Ph.D., Sr. Staff Scientist, Electrophysiology
Poster: Differential Effects of TC-5214 [S-(+)-mecamylamine] and TC-5213
[R-(-)-mecamylamine] at Low and High Sensitivity Human a4b2 Nicotinic Receptors and in Animal Models of Depression and Anxiety
Saturday, November 3, 2007 at 3 pm, #39.7, Board F38
Presenter: Kristen Jordan, Ph.D., Group Leader, Behavioral Neuroscience
Poster: TC-6499: An Orally Effective and Selective alpha4beta2 Neuronal Nicotinic Receptor Agonist with Anti-allodynic Activity
Saturday, November 3, 2007 at 3 p.m., Annual Brain Awareness Campaign Event, Room 17 AB
Presenter: Debra Perret, Communications Coordinator
Poster: Got Brains? We Do! Bringing the Brain to Audiences in NC’s Triad Region
- Nicotinic Acetylcholine Receptors as Therapeutic Targets: Emerging Frontiers in Basic Research & Clinical Science
Satellite to the 2007 Meeting of the Society for Neuroscience
October 31 - November 2, 2007
San Diego Convention Center
San Diego, CA, USA
Presenter: Geoffrey C. Dunbar, M.D., Vice President, Clinical Development and Regulatory Affairs, Targacept
November 1, 10:25 AM – Session 2: Alzheimer’s Disease
Presentation: Targeting a4ß2 nAChRs to Treat Cognitive Impairments in the Elderly: Clinical Trials with TC-1734 (AZD-3480) in AAMI and MCI
Presenter: Ramana Kuchibhatla, Ph.D., President & CEO, Ventureast Pharmaceutical Services
November 2, 10:00 AM – Session 7: ADHD, Depression and Epilepsy
Presentation: Clinical Studies with Mecamylamine in MDD Patients Non-Responsive to First-Line SSRI Treatment
- Women's Cognitive Health: Continuing the Dialogue
Cutting Edge Translational Research
October 24-26, 2007
Graylyn International Conference Center of Wake Forest University
Winston-Salem, NC
Presenter: Geoffrey C. Dunbar, M.D., Vice President, Clinical Development and Regulatory Affairs, Targacept
Wendesday, October 25, 3:00 p.m.
Presentation: Mecamylamine Augmentation Treatment in Major Depressive Disorder
- European College of Neuropsychopharmacology
October 13 - 17, 2007
Austria Center Vienna
Vienna, Austria Presenter: Patrick Lippiello, Senior Director, Project Planning and Scientific Communication, Targacept
Tuesday, October 15, 12 noon - 2:00 PM
Poster: Novel neuronal nicotinic receptor selective compounds for the treatment of acute, chronic and neuropathic pain. Presenter: Merouane Bencherif, M.D., Ph.D., Vice President, Preclinical Research, Targacept Tuesday, October 16, 12 noon - 2:00 PM
Poster: TC-4214 ((S)-(+) Mecamylamine) demonstrates antidepressant and anxiolytic effects in multiple animal models.
- British Association for Psychopharmacology Summer Meeting 2007
July 22 - 25, 2007
Harrogate International Centre
Harrogate, United Kingdom
Presenter: Geoffrey C. Dunbar, M.D., Vice President, Clinical Development and Regulatory Affairs, Targacept
Tuesday, July 24, 2:00 PM - Group A: Affective Disorders
Poster: Mecamylamine in the treatment for depressed patients who were non responders to citalopram first line therapy: A double-blind placebo controlled study.
- NCDEU 47th Annual Meeting
June 11 - 14, 2007
Mizner Center
Boca Raton, FL
Presenter: Geoffrey C. Dunbar, M.D., Vice President, Clinical Development and Regulatory Affairs, Targacept
Tuesday, June 12, 12:00 - 2:00 – Poster Session I
Poster: Activation of Neuronal Nicotinic Receptors (NNRs) in Healthy Volunteers Causes EEG Changes Which Precede Improvement in Attention and Episodic Memory
- Association for Computing Machinery
The 45th ACM Southeast Conference
March 23 - 24, 2007
M. C. Benton Jr. Convention and Civic Center
Winston-Salem, North Carolina
Presenters: David Vestal & Terrie Thoma, Noregon; Jeffrey Schmitt & Rebecca Harris, Targacept
Saturday, March 24, 1:45 - 3:50 p.m.
Presentation: High-Performance, Low-Cost Grid Computing Through Community Cooperation
- 8th International Conference: Alzheimer’s Disease and Parkinson’s Disease
March 14-18, 2007
Salzburg Congress Centre
Salzburg, Austria
Presenter: Geoffrey C. Dunbar, M.D., Vice President, Clinical Development and Regulatory Affairs,
3/15/2007 -- 10:00 a.m.
Presentation: AZD3480 (TC-1734): Early Development in Volunteers and Elderly Subjects Indicating a Beneficial Effect on Cognition
| | |  | |  | |
|
